18716777

Source:http://linkedlifedata.com/resource/pubmed/id/18716777

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0030705, umls-concept:C0144576, umls-concept:C0178602, umls-concept:C0205195, umls-concept:C0205390, umls-concept:C0243095, umls-concept:C0278488, umls-concept:C0332174, umls-concept:C0525079, umls-concept:C1640570, umls-concept:C2603343
pubmed:issue	5
pubmed:dateCreated	2009-2-26
pubmed:abstractText	The aim of the RiTa trial is to establish a feasible combination of bendamustine and paclitaxel in a weekly schedule in anthracycline pre-treated metastatic breast cancer patients.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7806519
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Nitrogen Mustard Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel, http://linkedlifedata.com/resource/pubmed/chemical/bendamustine
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	1432-0843
pubmed:author	pubmed-author:HeinrichGeorgG, pubmed-author:LoiblSibylleS, pubmed-author:MüllerLotharL, pubmed-author:MurmannCarolineC, pubmed-author:NekljudovaValentinaV, pubmed-author:SchwedlerKatrinK, pubmed-author:WarmMathiasM, pubmed-author:von MinckwitzGunterG
pubmed:issnType	Electronic
pubmed:volume	63
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	953-8
pubmed:meshHeading	pubmed-meshheading:18716777-Adult, pubmed-meshheading:18716777-Aged, pubmed-meshheading:18716777-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:18716777-Bone Neoplasms, pubmed-meshheading:18716777-Breast Neoplasms, pubmed-meshheading:18716777-Disease-Free Survival, pubmed-meshheading:18716777-Dose-Response Relationship, Drug, pubmed-meshheading:18716777-Feasibility Studies, pubmed-meshheading:18716777-Female, pubmed-meshheading:18716777-Humans, pubmed-meshheading:18716777-Liver Neoplasms, pubmed-meshheading:18716777-Lung Neoplasms, pubmed-meshheading:18716777-Lymphatic Metastasis, pubmed-meshheading:18716777-Middle Aged, pubmed-meshheading:18716777-Neoplasm Staging, pubmed-meshheading:18716777-Nitrogen Mustard Compounds, pubmed-meshheading:18716777-Paclitaxel, pubmed-meshheading:18716777-Pleural Neoplasms, pubmed-meshheading:18716777-Survival Rate, pubmed-meshheading:18716777-Treatment Outcome
pubmed:year	2009
pubmed:articleTitle	Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: RiTa trial.
pubmed:affiliation	German Breast Group, GBG-Forschungs GmbH, Schleussnerstrasse 42, 63263, Neu-Isenburg, Germany. sibylle.loibl@germanbreastgroup.de
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't, Clinical Trial, Phase I